IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
HER2 Positive Breast Cancer
National Cancer Institute (NCI)monoclonal_antibodyPhase 1/2Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 44/ 100
- Competitive Position
- 89/ 100
Competitive context
5 Active assets in the HER2 Positive Breast Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Vinorelbine Jazz Pharmaceuticals | Phase 3 | BBB |
Epirubicin Shanghai JMT-Bio Inc. | Phase 3 | BB |
Trastuzumab Sc Peking University Cancer Hospital & Institute | Phase 3 | BB |
Ferric Carboxymaltose [Ferinject] GBG Forschungs GmbH | Phase 3 | B |
FERRIC CATION GBG Forschungs GmbH | Phase 3 | B |
View all 14 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →